IBD Forum 2025

Zunfthaus zur Zimmerleuten

Dear Colleagues,

It is our great pleasure to invite you to the next edition of the IBD FORUM on June 24, 2025. The IBD FORUM is an interactive educational format, where clinical situations from your everyday practice will be discussed by experts and the current data on them will be presented in lectures. We invite you to take the opportunity to contribute your own cases from your everyday practice.

We are pleased to have as guest speaker on June 24, 2025 Dr. Bruce E. Sands from Mount Sinai Hospital, New York eluting on «Acceleration in IBD Treatment: How early and holistic care leads to better outcomes».

As keynote speaker at the second IBD FORUM of the year, we are delighted to welcome Prof. Alexander Moschen on the topic of ‘Redefining IBD Treatment Innovative Solutions for Unmet Patient Need’.

Kind regards,

Gerhard Rogler, Stephan Vavricka, Bernhard Sauter, Luc Biedermann und Pascal Frei

Registration

Program

24. Juni
4. November
19:00
Begrüssung
Gerhard Rogler, Stephan Vavricka, Bernhard Sauter, Luc Biedermann, Pascal Frei
19:15
Acceleration in IBD Treatment: How early and holistic care leads to better outcomes
Bruce E. Sands
20:00
Fälle aus der Praxis und Diskussionen
Gerhard Rogler, Stephan Vavricka, Bernhard Sauter, Luc Biedermann, Pascal Frei
20:40
Apéro

Faculty

Gerhard Rogler
Prof. Dr. med. Dr. phil.

Klinikleiter Gastroenterologie und Hepatologie

UniversitätsSpital Zürich

Stephan Vavricka
Prof. Dr. med.

Zentrum für Gastroenterologie und Hepatologie


Bernhard Sauter
Prof. Dr. med.

GastroZentrum Hirslanden

Zürich

Luc Biedermann
Prof. Dr. med.

Leiter IBD Unit

UniversitätsSpital Zürich

Pascal Frei
PD Dr. med.

Gastroenterologie Bethanien

Bruce E. Sands
MD, Boston University School of Medicine

Gastroenterology, Mount Sinai New York

Alexander Moschen
Univ.-Prof. Dr.

Universitätsklinik Linz

Location

Zunfthaus zur Zimmerleuten

Limmatquai 40, Zürich
8001 Zürich

Sponsors

AbbVie AG
Sponsor

About AbbVie
We are a global, research-based biopharmaceutical company focused on the discovery and development of innovative treatments that address some of the world’s most serious and complex diseases. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care and virology. In addition, AbbVie offers products and services through its Allergan Aesthetics portfolio. Patients in more than 175 countries benefit from AbbVie medications.

AbbVie with headquarters in Chicago, USA, employs over 50,000 employees worldwide. Approximately 280 employees are employed in Switzerland and the AbbVie Switzerland headquarters are located in Cham, ZG.

For more information, visit our website: www.abbvie.ch

Flyer:
Abbvie Symposium 11.09.2025
RINVOQ

Johnson & Johnson
Sponsor

Safe Returns Programm D
Programme Safe Returns F
Tremfya D
Tremfya F
Stelara D
Stelara F